Pharmacological analysis of postjunctional α‐adrenoceptors mediating contractions to (−)‐noradrenaline in the rabbit isolated lateral saphenous vein can be explained by interacting responses to simultaneous activation of α1‐and α2‐adrenoceptors
Open Access
- 1 October 1988
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 95 (2) , 485-500
- https://doi.org/10.1111/j.1476-5381.1988.tb11669.x
Abstract
The pharmacological characteristics of the α‐adrenoceptor population in the rabbit isolated saphenous vein has been examined with (–)‐noradrenaline (NA), as principal agonist, and a number of antagonists with selectivity for either α1‐ or α2‐adrenoceptors. The rank order of potency of various agonists is consistent with a population of α2‐adrenoceptors; UK‐14304 > (—)‐noradrenaline = (—)‐adrenaline > B‐HT 920 = cirazoline > phenylephrine > amidephrine, but the rank order of pA2 values for the antagonists against (—)− noradrenaline: BDF‐6143 > rauwolscine = prazosin > CH‐38083 = YM‐12617 > Wy‐26703 = phentolamine > corynanthine, is indicative of a mixed population of α1‐ and α2‐adrenoceptors or, alternatively, a new subtype with characteristics of both the α1‐ and α2‐subtypes. Further evidence for two discrete populations of α‐adrenoceptors is provided by, (a) the potent but non‐competitive effect of prazosin against (—)‐noradrenaline, (b) the presence of a component of the contractions elicited by NA and phenylephrine which is resistant to the selective α2‐adrenoceptor antagonists rauwolscine and CH‐38083: these responses were inhibited by the selective α1‐adrenoceptor antagonists prazosin and YM‐12617, but not by the selective α2‐adrenoceptor antagonist BDF‐6143 and, (c) the relative potency of the yohimbine diastereoisomers rauwolscine and corynanthine against NA, phenylephrine and UK‐14304. In spite of the overwhelming evidence for a population of postjunctional α2‐adrenoceptors, prazosin was similarly effective against all agonists and failed to discriminate between those with putative selectivity for α1‐ and α2‐adrenoceptors. This suggests an interaction of the effects of agonists at the two α‐adrenoceptor subtypes. An attempt has been made to reconcile a number of paradoxical observations with regard to the identification of postjunctional α2‐adrenoceptors in vitro, and it is suggested that in many of the isolated blood vessels presently available for examination both subtypes reside on the same smooth muscle cell. The pharmacological consequences of multiple subtypes of receptors mediating the same response is considered.This publication has 46 references indexed in Scilit:
- Postsynaptic α-adrenoceptor characterization and Ca2+ channel antagonist and activator actions in rat tail arteries from normotensive and hypertensive animalsCanadian Journal of Physiology and Pharmacology, 1986
- Evidence for and against heterogeneity of alpha1-adrenoceptorsLife Sciences, 1986
- Heterogeneity of alpha-2 adrenergic receptorsPharmacology Biochemistry and Behavior, 1985
- Evidence for more than one type of post-junctional α-AdrenoceptorBiochemical Pharmacology, 1982
- A Pharmacological Analysis of the α-Adrenoceptor Antagonism by Prazosin in Arteries and VeinsJournal of Vascular Research, 1982
- UK-14,304, a potent and selective α2-agonist for the characterisation of α-adrenoceptor subtypesEuropean Journal of Pharmacology, 1981
- Postsynaptic α-Adrenoceptor Subtypes in Rabbit Blood Vessels and Rat Anococcygeus Muscle Studied In VitroJournal of Cardiovascular Pharmacology, 1981
- Evidence for nonclassical alpha adrenoceptor blockade by prazosin in isolated rabbit blood vesselsLife Sciences, 1980
- Studies on the mechanism of the vasodilator effects of prazosin in dogs and rabbitsEuropean Journal of Pharmacology, 1978
- On the Measurement of Vascular and Respiratory Smooth Muscle Responses in vitroJournal of Vascular Research, 1977